Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer
- 31 March 2007
- journal article
- review article
- Published by Elsevier BV in European Urology
- Vol. 51 (3), 605-613
- https://doi.org/10.1016/j.eururo.2006.10.062
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Identifying Patients at Risk for Significant Versus Clinically Insignificant Postoperative Prostate-Specific Antigen FailureJournal of Clinical Oncology, 2005
- Risk of Prostate Cancer–Specific Mortality Following Biochemical Recurrence After Radical ProstatectomyJAMA, 2005
- EAU Guidelines on Prostate CancerEuropean Urology, 2005
- CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTSJournal of Urology, 2004
- Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate CancerJournal of Urology, 2003
- Determinants of Prostate Cancer–Specific Survival After Radiation Therapy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2002
- Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA eraInternational Journal of Radiation Oncology*Biology*Physics, 2002
- LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMYUrologic Clinics of North America, 2001
- Radiation Therapy for Clinically Localized Prostate CancerJAMA, 1999
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999